DO-RE-ME 25mg 10 Tablets

Babies: It is not applicable for babies. Lactating mother: It is unsafe during breastfeeding.
Limited human studies suggest that the drug may pass into the breastmilk and harm the baby Pregnancy: It is unsafe to use this medicine during pregnancy. Limited human studies have shown harmful effects on the developing baby.
Seek doctor advice before using this medication. Driving: It is unknown whether the do-re-me tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Alcohol: While consuming alcohol with a do-re-me tablet, it may cause excessive drowsiness Kidney: There is limited information available on the use of do-re-me tablets in patients with kidney disease.
Seek doctor advice before using this medication. Liver: There is limited information on the use of do-re-me tablets in patients with liver disease.
Seek doctor advice before using this medication. .

Dryness in mouth Increased heart rate Orthostatic hypotension Weight gain Difficulty in urination Constipation Blurred vision.

Do-re-me tablet is a tricyclic antidepressant. It works by increasing the levels of chemical messengers in the brain that helps in regulating mood and treat depression..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Do-re-me tablets may works from 4 to 6 weeks for the do-re-me tablet. Keep taking it as prescribed by your doctor • It may cause sleepiness.
Take it at bedtime and do not drive or do anything requiring concentration until you know how it affects you. • Avoid consuming alcohol when taking do-re-me tablets as it may cause excessive sleepiness. • Monitor your weight during the treatment as this medicine can cause weight gain and increased appetite. • Inform your doctor if you experience sudden mood changes and any suicidal thoughts.

• Do-re-me + Abatacept: Concurrent use leads to increased metabolism of do-re-me • Do-re-me + Acarbose: Concurrent use leads to decreased hypoglycemic activities of acarbose • Do-re-me + Arsenic trioxide: Concurrent use leads increases the risk or severity of qtc prolongation • Do-re-me + Baclofen: Concurrent use leads to decreases the risk or severity of cns depression and hypotonia • Do-re-me + Axitinib: Concurrent use leads to decreases in the metabolism of axitinib.